Tobias Assander joins Disruptive Pharma as Manufacturing and Process Development Lead

We are pleased to welcome Tobias Assander to Disruptive Pharma as Formulite® Manufacturing and Process Development Lead.

Tobias brings broad experience from the pharmaceutical industry and will lead activities related to process development, scale-up and manufacturing of Formulite®. His role will be important as we continue strengthening our capabilities to support future partner projects and prepare for larger-scale manufacturing.

Formulite® is designed to improve the bioavailability of poorly soluble oral drugs, with the potential to enable more effective and patient-friendly medicines. Developing robust and scalable manufacturing processes is an important part of bringing the technology into pharmaceutical development and future commercial use.

Tobias has previously worked with Disruptive Pharma, making this a welcome return to the team and allowing him to build on his existing knowledge of the company and the Formulite® platform.

We are very happy to have Tobias back as we continue developing and scaling Formulite®.

Welcome back, Tobias!